Edick Paul R
Insider CIK 1531178 · (NLNK) Director · XERS See Remarks, Director · SCMP Director · MIST Director · VTGN Director · NEOS Director · DRTX Chief Executive Officer, Director · ITRM Director · XERS See Remarks, Director · PDLI Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| VTGN Vistagen Therapeutics, Inc | A Award deriv | 2025-10-27 | 2025-11-04 | 35,200 | — | $0 | 35,200 | SEC↗ |
| XERS Xeris Biopharma Holdings, | A Award deriv | 2024-01-31 | 2024-01-31 | 500,000 | — | $0 | 500,000 | SEC↗ |
| XERS Xeris Biopharma Holdings, | A Award | 2024-01-31 | 2024-01-31 | 1,500,000 | — | $0 | 3,788,064 | SEC↗ |
| XERS Xeris Biopharma Holdings, | P Buy | 2023-08-09 | 2023-08-09 | 10,000 | $2.38 | $23.8K | 2,288,064 | SEC↗ |
| XERS Xeris Biopharma Holdings, | A Award | 2023-01-31 | 2023-02-01 | 750,000 | — | $0 | 2,278,064 | SEC↗ |
| XERS Xeris Biopharma Holdings, | P Buy | 2022-12-13 | 2022-12-14 | 20,000 | $1.45 | $29.0K | 1,528,064 | SEC↗ |
| XERS Xeris Biopharma Holdings, | P Buy | 2022-05-12 | 2022-05-13 | 100,000 | $1.40 | $140.0K | 1,508,064 | SEC↗ |
| XERS Xeris Biopharma Holdings, | A Award | 2022-01-03 | 2022-01-05 | 600,000 | — | $0 | 1,408,064 | SEC↗ |
| XERS Xeris Biopharma Holdings, | P Buy | 2021-11-15 | 2021-11-16 | 20,000 | $2.28 | $45.6K | 33,430 | SEC↗ |
| XERS Xeris Biopharma Holdings, | P Buy | 2021-11-11 | 2021-11-12 | 200,000 | $2.08 | $416.0K | 808,064 | SEC↗ |
| XERS XERIS PHARMACEUTICALS INC | D To issuer deriv | 2021-10-05 | 2021-10-05 | 668,065 | — | $0 | 0 | SEC↗ |
| XERS XERIS PHARMACEUTICALS INC | D To issuer deriv | 2021-10-05 | 2021-10-05 | 69,822 | — | $0 | 0 | SEC↗ |
| XERS XERIS PHARMACEUTICALS INC | D To issuer deriv | 2021-10-05 | 2021-10-05 | 98,252 | — | $0 | 0 | SEC↗ |
| XERS XERIS PHARMACEUTICALS INC | D To issuer deriv | 2021-10-05 | 2021-10-05 | 400,000 | — | $0 | 0 | SEC↗ |
| XERS XERIS PHARMACEUTICALS INC | D To issuer deriv | 2021-10-05 | 2021-10-05 | 200,000 | — | $0 | 0 | SEC↗ |
| XERS Xeris Biopharma Holdings, | A Award deriv | 2021-10-05 | 2021-10-05 | 98,252 | — | $0 | 98,252 | SEC↗ |
| XERS Xeris Biopharma Holdings, | A Award deriv | 2021-10-05 | 2021-10-05 | 200,000 | — | $0 | 200,000 | SEC↗ |
| XERS Xeris Biopharma Holdings, | A Award deriv | 2021-10-05 | 2021-10-05 | 400,000 | — | $0 | 400,000 | SEC↗ |
| XERS Xeris Biopharma Holdings, | A Award deriv | 2021-10-05 | 2021-10-05 | 69,822 | — | $0 | 69,822 | SEC↗ |
| XERS Xeris Biopharma Holdings, | A Award deriv | 2021-10-05 | 2021-10-05 | 668,065 | — | $0 | 668,065 | SEC↗ |
| XERS XERIS PHARMACEUTICALS INC | D To issuer | 2021-10-05 | 2021-10-05 | 13,430 | — | $0 | 0 | SEC↗ |
| XERS XERIS PHARMACEUTICALS INC | D To issuer | 2021-10-05 | 2021-10-05 | 197,231 | — | $0 | 410,833 | SEC↗ |
| XERS XERIS PHARMACEUTICALS INC | D To issuer | 2021-10-05 | 2021-10-05 | 410,833 | — | $0 | 0 | SEC↗ |
| XERS Xeris Biopharma Holdings, | A Award | 2021-10-05 | 2021-10-05 | 410,833 | — | $0 | 608,064 | SEC↗ |
| XERS Xeris Biopharma Holdings, | A Award | 2021-10-05 | 2021-10-05 | 13,430 | — | $0 | 13,430 | SEC↗ |
| XERS Xeris Biopharma Holdings, | A Award | 2021-10-05 | 2021-10-05 | 197,231 | — | $0 | 197,231 | SEC↗ |
| XERS XERIS PHARMACEUTICALS INC | A Award deriv | 2021-01-29 | 2021-02-01 | 400,000 | — | $0 | 400,000 | SEC↗ |
| XERS XERIS PHARMACEUTICALS INC | A Award | 2021-01-29 | 2021-02-01 | 225,000 | — | $0 | 636,134 | SEC↗ |
| XERS XERIS PHARMACEUTICALS INC | P Buy | 2020-12-09 | 2020-12-10 | 10,000 | $4.06 | $40.6K | 411,134 | SEC↗ |
| MIST Milestone Pharmaceuticals | A Award deriv | 2020-06-05 | 2020-06-08 | 15,000 | — | $0 | 15,000 | SEC↗ |
| XERS XERIS PHARMACEUTICALS INC | P Buy | 2020-05-08 | 2020-05-11 | 33,000 | $3.00 | $99.0K | 401,134 | SEC↗ |
| XERS XERIS PHARMACEUTICALS INC | P Buy | 2020-02-14 | 2020-02-18 | 20,000 | $4.15 | $83.0K | 183,134 | SEC↗ |
| XERS XERIS PHARMACEUTICALS INC | F Tax w/h | 2020-01-31 | 2020-02-04 | 9,801 | $6.37 | $62.4K | 163,134 | SEC↗ |
| XERS XERIS PHARMACEUTICALS INC | A Award | 2020-01-31 | 2020-03-02 | 185,000 | — | $0 | 368,134 | SEC↗ |
| XERS XERIS PHARMACEUTICALS INC | P Buy | 2019-11-25 | 2019-11-27 | 17,935 | $8.55 | $153.3K | 172,935 | SEC↗ |
| ITRM Iterum Therapeutics plc | M Exercise deriv | 2019-05-24 | 2019-05-29 | 6,154 | — | $0 | 0 | SEC↗ |
| ITRM Iterum Therapeutics plc | M Exercise | 2019-05-24 | 2019-05-29 | 6,154 | — | $0 | 31,390 | SEC↗ |
| XERS XERIS PHARMACEUTICALS INC | P Buy | 2019-03-11 | 2019-03-12 | 30,000 | $9.12 | $273.6K | 155,000 | SEC↗ |
| XERS XERIS PHARMACEUTICALS INC | A Award deriv | 2019-01-31 | 2019-02-01 | 200,000 | — | $0 | 200,000 | SEC↗ |
| XERS XERIS PHARMACEUTICALS INC | A Award | 2019-01-31 | 2019-02-01 | 125,000 | — | $0 | 125,000 | SEC↗ |
| ITRM Iterum Therapeutics plc | P Buy | 2018-08-23 | 2018-08-27 | 500 | $10.44 | $5.2K | 25,236 | SEC↗ |
| XERS XERIS PHARMACEUTICALS INC | C Conversion deriv | 2018-06-25 | 2018-06-27 | 23,922 | — | $0 | 0 | SEC↗ |
| XERS XERIS PHARMACEUTICALS INC | C Conversion | 2018-06-25 | 2018-06-27 | 13,430 | — | $0 | 13,430 | SEC↗ |
| PDLI PDL BIOPHARMA, INC. | A Award | 2018-06-08 | 2018-06-12 | 54,348 | $2.76 | $150.0K | 214,563 | SEC↗ |
| ITRM Iterum Therapeutics plc | C Conversion deriv | 2018-05-30 | 2018-05-30 | 15,913 | — | $0 | 0 | SEC↗ |
| ITRM Iterum Therapeutics plc | C Conversion deriv | 2018-05-30 | 2018-05-30 | 1,591 | — | $0 | 0 | SEC↗ |
| ITRM Iterum Therapeutics plc | C Conversion deriv | 2018-05-30 | 2018-05-30 | 4,050 | — | $0 | 0 | SEC↗ |
| ITRM Iterum Therapeutics plc | C Conversion | 2018-05-30 | 2018-05-30 | 4,050 | — | $0 | 23,145 | SEC↗ |
| ITRM Iterum Therapeutics plc | C Conversion | 2018-05-30 | 2018-05-30 | 15,913 | — | $0 | 19,095 | SEC↗ |
| ITRM Iterum Therapeutics plc | C Conversion | 2018-05-30 | 2018-05-30 | 1,591 | — | $0 | 24,736 | SEC↗ |
| ITRM Iterum Therapeutics plc | A Award deriv | 2018-05-24 | 2018-05-29 | 6,154 | — | $0 | 6,154 | SEC↗ |
| SCMP Sucampo Pharmaceuticals, I | D To issuer deriv | 2018-02-13 | 2018-02-13 | 10,000 | $7.70 | $77.0K | 0 | SEC↗ |
| SCMP Sucampo Pharmaceuticals, I | D To issuer | 2018-02-13 | 2018-02-13 | 14,930 | $18.00 | $268.7K | 0 | SEC↗ |
| NEOS Neos Therapeutics, Inc. | A Award deriv | 2017-07-03 | 2017-07-05 | 18,322 | — | $0 | 18,322 | SEC↗ |
| PDLI PDL BIOPHARMA, INC. | A Award | 2017-06-09 | 2017-06-12 | 60,729 | $2.47 | $150.0K | 160,215 | SEC↗ |
| SCMP Sucampo Pharmaceuticals, I | A Award deriv | 2017-06-01 | 2017-07-07 | 10,000 | — | $0 | 10,000 | SEC↗ |
| SCMP Sucampo Pharmaceuticals, I | A Award | 2017-06-01 | 2017-07-07 | 5,130 | — | $0 | 19,830 | SEC↗ |
| SCMP Sucampo Pharmaceuticals, I | A Award deriv | 2017-06-01 | 2017-06-05 | 10,000 | — | $0 | 10,000 | SEC↗ |
| SCMP Sucampo Pharmaceuticals, I | A Award | 2017-06-01 | 2017-06-05 | 5,130 | — | $0 | 14,930 | SEC↗ |
| (NLNK) NEWLINK GENETICS CORP | A Award deriv | 2017-05-12 | 2017-05-16 | 13,309 | — | $0 | 13,309 | SEC↗ |
| (NLNK) NEWLINK GENETICS CORP | A Award deriv | 2016-08-09 | 2016-08-11 | 4,783 | — | $0 | 4,783 | SEC↗ |
| (NLNK) NEWLINK GENETICS CORP | A Award deriv | 2016-08-09 | 2016-08-11 | 17,773 | — | $0 | 17,773 | SEC↗ |
| SCMP Sucampo Pharmaceuticals, I | A Award | 2016-08-01 | 2016-08-03 | 14,700 | — | $0 | 14,700 | SEC↗ |
| NEOS Neos Therapeutics, Inc. | A Award deriv | 2016-07-01 | 2016-07-05 | 14,777 | — | $0 | 14,777 | SEC↗ |
| PDLI PDL BIOPHARMA, INC. | A Award | 2016-06-02 | 2016-06-03 | 71,023 | $3.52 | $250.0K | 99,486 | SEC↗ |
| PDLI PDL BIOPHARMA, INC. | A Award | 2015-09-08 | 2015-09-08 | 28,463 | $5.27 | $150.0K | 28,463 | SEC↗ |
| (NLNK) NEWLINK GENETICS CORP | A Award deriv | 2015-04-30 | 2015-07-17 | 6,349 | — | $0 | 6,349 | SEC↗ |
| (NLNK) NEWLINK GENETICS CORP | A Award deriv | 2015-04-30 | 2015-05-04 | 3,643 | — | $0 | 3,643 | SEC↗ |
| (NLNK) NEWLINK GENETICS CORP | A Award | 2015-04-30 | 2015-05-04 | 1,962 | — | $0 | 7,906 | SEC↗ |
| DRTX Durata Therapeutics, Inc. | D To issuer deriv | 2014-11-17 | 2014-11-18 | 42,234 | — | $0 | 0 | SEC↗ |
| DRTX Durata Therapeutics, Inc. | D To issuer deriv | 2014-11-17 | 2014-11-18 | 656,250 | — | $0 | 0 | SEC↗ |
| DRTX Durata Therapeutics, Inc. | D To issuer deriv | 2014-11-17 | 2014-11-18 | 100,000 | — | $0 | 0 | SEC↗ |
| DRTX Durata Therapeutics, Inc. | D To issuer deriv | 2014-11-17 | 2014-11-18 | 12,500 | — | $0 | 0 | SEC↗ |
| DRTX Durata Therapeutics, Inc. | D To issuer deriv | 2014-11-17 | 2014-11-18 | 300,000 | — | $0 | 0 | SEC↗ |
| DRTX Durata Therapeutics, Inc. | D To issuer | 2014-11-17 | 2014-11-18 | 45,636 | — | $0 | 0 | SEC↗ |
| DRTX Durata Therapeutics, Inc. | D To issuer | 2014-11-17 | 2014-11-18 | 500 | — | $0 | 0 | SEC↗ |
| DRTX Durata Therapeutics, Inc. | P Buy | 2014-06-12 | 2014-06-13 | 3,000 | $15.23 | $45.7K | 45,636 | SEC↗ |
| DRTX Durata Therapeutics, Inc. | A Award deriv | 2014-05-21 | 2014-05-22 | 300,000 | — | $0 | 1,110,984 | SEC↗ |
| (NLNK) NEWLINK GENETICS CORP | A Award deriv | 2014-05-01 | 2015-07-17 | 15,659 | — | $0 | 15,659 | SEC↗ |
| (NLNK) NEWLINK GENETICS CORP | A Award deriv | 2014-05-01 | 2014-05-05 | 8,331 | — | $0 | 8,331 | SEC↗ |
| (NLNK) NEWLINK GENETICS CORP | A Award | 2014-05-01 | 2014-05-05 | 2,944 | — | $0 | 5,944 | SEC↗ |
| (NLNK) NEWLINK GENETICS CORP | A Award | 2014-01-02 | 2014-01-06 | 3,000 | — | $0 | 3,000 | SEC↗ |
| DRTX Durata Therapeutics, Inc. | P Buy | 2013-05-20 | 2013-05-20 | 3,000 | $7.09 | $21.3K | 43,136 | SEC↗ |
| (NLNK) NEWLINK GENETICS CORP | A Award deriv | 2013-05-09 | 2013-05-10 | 12,000 | — | $0 | 12,000 | SEC↗ |
| DRTX Durata Therapeutics, Inc. | A Award deriv | 2013-02-12 | 2013-02-14 | 100,000 | $7.49 | $749.0K | 810,984 | SEC↗ |
| NLNK NEWLINK GENETICS CORP | A Award deriv | 2012-11-02 | 2012-11-06 | 9,522 | — | $0 | 9,522 | SEC↗ |
| DRTX Durata Therapeutics, Inc. | P Buy | 2012-08-14 | 2012-08-16 | 5,000 | $8.65 | $43.3K | 24,636 | SEC↗ |
| DRTX Durata Therapeutics, Inc. | C Conversion deriv | 2012-07-24 | 2012-07-26 | 157,088 | — | $0 | 0 | SEC↗ |
| DRTX Durata Therapeutics, Inc. | C Conversion | 2012-07-24 | 2012-07-26 | 19,636 | — | $0 | 19,636 | SEC↗ |
| DRTX Durata Therapeutics, Inc. | P Buy deriv | 2012-03-15 | 2012-07-26 | 44,767 | $1.00 | $44.8K | 157,088 | SEC↗ |
| (NLNK) NEWLINK GENETICS CORP | A Award deriv | 2012-01-19 | 2012-01-23 | 2,381 | — | $0 | 2,381 | SEC↗ |